½ÃÀ庸°í¼­
»óǰÄÚµå
1673075

Àΰø½ÉÀåÆÇ¸· ½ÃÀå : À§Ä¡ À¯Çüº°, ÆÇ¸· À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Prosthetic Heart Valve Market, By Position Type, By Valve Type, By End User,, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Àΰø½ÉÀåÆÇ¸· ½ÃÀåÀº 2025³â¿¡ 147¾ï 6,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 320¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ CAGR 11.7%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 147¾ï 6,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 11.70% 2032³â ±Ý¾× ¿¹Ãø 320¾ï 4,000¸¸ ´Þ·¯
µµÇ¥. Àΰø½ÉÀåÆÇ¸· ½ÃÀå Áö¿ªº° Á¡À¯À²(%)(2025³â)
Prosthetic Heart Valve Market-IMG1

Àΰø½ÉÀåÆÇ¸· ½ÃÀåÀº ½ÉÀåÆÇ¸·Áõ À¯º´·ü Áõ°¡¿Í ÆÇ¸· ±³Ã¼ ¼ö¼ú °Ç¼ö Áõ°¡·Î ÀÎÇØ Áö³­ ¼ö³â°£ ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Àΰø½ÉÀåÆÇ¸·Àº Á¦´ë·Î ÀÛµ¿ÇÏÁö ¾Ê´Â ¼Õ»óµÈ ½ÉÀå ÆÇ¸·À» ´ëüÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. °í·ÉÈ­, Èí¿¬, ºñ¸¸, ´ç´¢º´ µîÀÇ À§Çè ¿äÀÎÀ¸·Î ÀÎÇØ ½Â¸ðÆÇ¸· Æó¼âºÎÀüÁõ, ´ëµ¿¸ÆÆÇ¸· Æó¼âºÎÀüÁõ, ÇùÂøÁõ°ú °°Àº ½ÉÀåÆÇ¸· ÁúȯÀ» ¾Î°í Àִ ȯÀÚ°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â°è½Ä ÆÇ¸·¿¡¼­ »ýü ÆÇ¸·À¸·ÎÀÇ ÆÇ¸· ¼³°è ±â¼ú ¹ßÀü°ú ÀÇ·áºñ Áõ°¡°¡ Àΰø½ÉÀåÆÇ¸· ½ÃÀåÀÇ ¼¼°è ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ä¡·áºñ¿ëÀº Àΰø½ÉÀåÆÇ¸·ÀÇ ±¤¹üÀ§ÇÑ º¸±ÞÀ» ÀúÇØÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÁÖ¿ä ±¹°¡ÀÇ ½ÉÀåÆÇ¸·Áõ ºÎ´ã Áõ°¡¿Í ÇÔ²² ³ëÀÎ Àα¸ Áõ°¡´Â Àΰø½ÉÀåÆÇ¸· ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­¸¸ 1,600¸¸ ¸í ÀÌ»óÀÌ ÆÇ¸· ÁúȯÀ» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ½ÃÀå °³¹ßÀÇ ÁÖ¿ä À§Çè ¿äÀÎÀÎ ºñ¸¸°ú ´ç´¢º´ÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» º¸¿ÏÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±âÁ¸ÀÇ °³½É¼úÀ» ´ëüÇÒ ¼ö ÀÖ´Â ±â¼úÀûÀ¸·Î Áøº¸µÈ Àúħ½ÀÀû °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸·ÀÇ µµÀÔÀÌ Á¡Â÷ ´ëÁßÈ­µÇ¸é¼­ ½ÃÀå ¸ÅÃâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÆÇ¸· ±³Ã¼ ¼ö¼ú¿¡ µû¸£´Â ¾öû³­ ºñ¿ëÀÌ Æ¯È÷ °³¹ßµµ»ó±¹¿¡¼­ÀÇ º¸±ÞÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ½ÅÁ¦Ç° ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Áöħµµ ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ±×·¯³ª Àú·ÅÇÑ °¡°ÝÀÇ Àåºñ¿Í Çâ»óµÈ ±â¼úÀ» °³¹ßÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ßÀº ÇâÈÄ ¼ö³â°£ Àΰø½ÉÀåÆÇ¸· Á¦Á¶¾÷üµé¿¡°Ô Å« ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ Àΰø½ÉÀåÆÇ¸·(Àΰø½ÉÀåÆÇ¸·) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¸ÅÃâ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è Àΰø ½ÉÀå ÆÇ¸· ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è Àΰø ½ÉÀå ÆÇ¸· ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Àΰø½ÉÀåÆÇ¸· ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå °³¿ä

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • °³¿ä
  • ½ÃÀå ±âȸ ¸Ê

Á¦3Àå Áß¿äÇÑ ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • PEST ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • ±â¼úÀÇ Áøº¸
  • ÇÕº´, Àμö, Çù¾÷ ½Ã³ª¸®¿À
  • ÃÖ±Ù Á¦Ç° ½ÂÀÎ
  • °¢ Áö¿ªÀÇ ÁÖ¿ä Âü¿© ±â¾÷ÀÇ ½Äº°
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • °¡°Ý ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿ªÇÐ
  • ±¹°¡¿¡ ÀÇÇÑ ÀÇ·áºñ ÁöÃâ
  • »óȯ ½Ã³ª¸®¿À
  • À¯Åë¾÷üÀÇ »óȲ
  • ºê·£µå ÁöµµÁ¦ÀÛ
  • °æÀïÀÇ ÇöȲ
  • ±â¾÷ Æ÷Áö¼Å´× ºÐ¼®
  • È÷Æ®¸Ê ºÐ¼®

Á¦4Àå ¼¼°èÀÇ Àΰø½ÉÀåÆÇ¸· ½ÃÀå, À§Ä¡ À¯Çüº°, 2020-2032³â

  • ¼­·Ð
  • ´ëµ¿¸ÆÆÇ
  • ½Â¸ðÆÇ
  • ±âŸ

Á¦5Àå ¼¼°èÀÇ Àΰø½ÉÀåÆÇ¸· ½ÃÀå, ÆÇ¸· À¯Çüº°, 2020-2032³â

  • ¼­·Ð
  • ±â°è ÆÇ¸·
  • Á¶Á÷ ÆÇ¸·
  • °æÄ«Å×ÅÍ ÆÇ¸·

Á¦6Àå ¼¼°èÀÇ Àΰø½ÉÀåÆÇ¸· ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

  • ¼­·Ð
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ä«Å×ÅÍ °Ë»ç½Ç
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Àΰø½ÉÀåÆÇ¸· ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ¼­·Ð
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • °æÀï ½º³À¼ô
  • ½ÃÀå Âü°¡ÀÚ ¼Ò¸®
  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ½ÃÀå Á¡À¯À² ºÐ¼®, 2025³â-¼¼°è

Á¦9Àå ±â¾÷ °³¿ä - ¼¼°èÀÇ Àΰø½ÉÀåÆÇ¸· ½ÃÀå

  • Edwards Lifesciences Corporation
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology Inc.
  • TTK Healthcare Limited
  • Lepu Medical Technology Co. Ltd
  • Foldax, Inc.
  • Symetis SA
  • On-X Life Technologies
  • Braile Biomedica

Á¦10Àå ¿î¸íÀÇ ¼ö·¹¹ÙÄû

  • ¿î¸íÀÇ ¼ö·¹¹ÙÄû
  • COM(Coherent Opportunity Map)

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
KSA 25.04.02

Global Prosthetic Heart Valve Market is estimated to be valued at USD 14.76 Bn in 2025 and is expected to reach USD 32.04 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 14.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.70% 2032 Value Projection: USD 32.04 Bn
Figure. Prosthetic Heart Valve Market Share (%), By Region 2025
Prosthetic Heart Valve Market - IMG1

The prosthetic heart valve market has been witnessing steady growth over the past few years owing to the increasing prevalence of heart valve diseases and rising number of valve replacement surgeries. Prosthetic heart valves help in replacing damaged heart valves that do not function properly. There has been a substantial increase in the patient pool suffering from heart valve conditions such as mitral and aortic regurgitation or stenosis due to aging population and risk factors like smoking, obesity, and diabetes. Moreover, technological advancements in valve design from mechanical valves to bioprosthetic valves and rising healthcare expenditure have been contributing towards the growth of the prosthetic heart valve market globally. However, high cost of treatment remains a key concern inhibiting wider adoption.

Market Dynamics:

Rising geriatric population base along with increasing burden of heart valve diseases across major countries act as the major growth drivers for the prosthetic heart valve market. As per estimates, over 16 million people suffer from valve diseases in the U.S. alone. The growing prevalence of obesity and diabetes which are major risk factors for developing valve defects supplement the market growth. Furthermore, introduction of technologically advanced, minimally invasive transcatheter heart valves as an alternative to conventional open-heart surgeries is gradually gaining adoption, bolstering the market revenues. However, prohibitively high costs associated with valve replacement surgeries limits widespread adoption, especially in developing regions. Stringent regulatory guidelines for new product approvals also impacts the market adversely. But ongoing R&D for developing affordable devices and enhanced technologies presents significant opportunities for prosthetic heart valve manufacturers over coming years.

Key Features of the Study:

  • This report provides an in-depth analysis of the global prosthetic heart valve market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global prosthetic heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study includes Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology , TTK Healthcare Limited , Lepu Medical Technology Co. Ltd , Foldax, Inc. , Symetis SA , On-X Life Technologies, and Braile Biomedica
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global prosthetic heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valve market

Market Segmentation

  • Valve Type:
    • Mechanical Valves
    • Tissue Valves
    • Transcatheter Valves
  • Position Type:
    • Aortic Valve
    • Mitral Valve
    • Others
  • End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Catheterization Laboratory
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Edwards Lifesciences Corporation
    • Medtronic plc.
    • Boston Scientific Corporation
    • Abbott Laboratories
    • LivaNova PLC
    • CryoLife Inc.
    • Braile Biomedica
    • Colibri Heart Valve LLC
    • JenaValve Technology Inc.
    • TTK Healthcare Limited
    • Lepu Medical Technology Co. Ltd
    • Foldax, Inc.
    • Symetis SA
    • On-X Life Technologies
    • Braile Biomedica

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Position Type
    • Market Snapshot, By Valve Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancements
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Identification of Key Players in Each Region
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Epidemiology
  • Healthcare Spending, by Country
  • Reimbursement Scenario
  • Distributors Landscape
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Prosthetic Heart Valve Market, By Position Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Aortic Valve, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Mitral Valve, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

5. Global Prosthetic Heart Valve Market, By Valve Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Mechanical Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Tissue Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Transcatheter Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

6. Global Prosthetic Heart Valve Market, By End User, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Hospitals, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Ambulatory Surgical Centers, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Catheterization Laboratory, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

7. Global Prosthetic Heart Valve Market, By Region, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Asean
      • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2025 - Global

9. Company Profiles - Global Prosthetic Heart Valve Market

  • Edwards Lifesciences Corporation*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology Inc.
  • TTK Healthcare Limited
  • Lepu Medical Technology Co. Ltd
  • Foldax, Inc.
  • Symetis SA
  • On-X Life Technologies
  • Braile Biomedica

10. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦